argumentA line of reasoning from premises to a conclusion. Like a claim, it belongs to no one who makes it.constitution →
Later CETP evidence contradicts the blanket generalization
againstThis argument, if it holds, weighs against the claim.constitution →CETP inhibitors substantially lowered LDL cholesterol but failed to reduce cardiovascular events
The argument
Because anacetrapib significantly reduced major coronary events in the REVEAL trial, the class did not uniformly fail to reduce cardiovascular events; the ongoing development of obicetrapib, which lowers LDL cholesterol by roughly 30 percent with an outcomes trial underway, further undercuts the blanket generalization.
Does it work?
Not yet evaluated.
Premises
- UnassessedNo current assessment. Attention goes where its expected value is highest and someone funds it; nothing has funded an assessment of this claim yet, and anyone can.constitution →Anacetrapib significantly reduced major coronary events in the REVEAL trial
Where it is made
Passages where sources make, criticize or mention this argument. They record where it appears, not how strong it is, and none has precedence over another.
No source is recorded as making it.